Vineeta Agarwala, Ph.D.
Affiliations: | 2013 | Biophysics | Harvard University, Cambridge, MA, United States |
Area:
human genetic variation and its application to diseaseGoogle:
"Vineeta Agarwala"Mean distance: 16.95 (cluster 32) | S | N | B | C | P |
Parents
Sign in to add mentor| David Altshuler | grad student | 2013 | Harvard | |
| (Integrating empirical data and population genetic simulations to study the genetic architecture of type 2 diabetes.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sinnott-Armstrong N, Tanigawa Y, Amar D, et al. (2021) Genetics of 35 blood and urine biomarkers in the UK Biobank. Nature Genetics |
| Flannick J, Fuchsberger C, Mahajan A, et al. (2018) Erratum: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls. Scientific Data. 5: 180002 |
| Jason F, Fuchsberger C, Mahajan A, et al. (2017) Sequence data and association statistics from 12,940 type 2 diabetes cases and controls. Scientific Data. 4: 170179 |
| Mercader JM, Liao RG, Davis A, et al. (2017) A Loss-Of-Function Splice Acceptor Variant in IGF2 is Protective for Type 2 Diabetes. Diabetes |
| Fuchsberger C, Flannick J, Teslovich TM, et al. (2016) The genetic architecture of type 2 diabetes. Nature |
| Moutsianas L, Agarwala V, Fuchsberger C, et al. (2015) The power of gene-based rare variant methods to detect disease-associated variation and test hypotheses about complex disease. Plos Genetics. 11: e1005165 |
| Wang SR, Agarwala V, Flannick J, et al. (2014) Simulation of Finnish population history, guided by empirical genetic data, to assess power of rare-variant tests in Finland. American Journal of Human Genetics. 94: 710-20 |
| Ran FA, Hsu PD, Wright J, et al. (2013) Genome engineering using the CRISPR-Cas9 system. Nature Protocols. 8: 2281-308 |
| Agarwala V, Flannick J, Sunyaev S, et al. (2013) Evaluating empirical bounds on complex disease genetic architecture. Nature Genetics. 45: 1418-27 |
| Flannick J, Beer NL, Bick AG, et al. (2013) Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes. Nature Genetics. 45: 1380-5 |